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ABSTRACT
The present study evaluated the molecular detection and identiﬁcation of Rickettsia species in 83 ticks
collected in Sardinia, Italy. Fifteen ticks were PCR-positive using gltA-speciﬁc and ompA-speciﬁc
primers, leading to the identiﬁcation of Rickettsia aeschlimannii in Hyalomma marginatum marginatum,
R. massiliae in Rhipicephalus turanicus and in Rhipicephalus sanguineus, and a new rickettsia, previously
referred to as PoTiRb169 in Portugal, in four Rhipicephalus turanicus. This new species was further
characterized by ampliﬁcation and sequencing of three additional genes (ompB, sca4 and rrs). Using the
current criteria to name a rickettsia, this uncultivated rickettsia can be given a Candidatus status, and we
propose to call it ‘Candidatus Rickettsia barbariae’. The detection of three tick-borne rickettsiae in
Sardinia raises the possibility that many cases of spotted fever considered by clinicians and health
authorities as Mediterranean spotted fever due to R. conorii could, in fact, be due to other rickettsiae,
including those found in this study. Analysing skin biopsies of inoculation eschars in patients with
spotted fever would be, together with continuing entomological surveys, the best way to increase our
knowledge of tick-borne rickettsioses in Sardinia and more generally in the Mediterranean basin.
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INTRODUCTION
Tick-borne spotted fever group (SFG) rickettsiae
are obligate intracellular, Gram-negative bacteria,
commonly associated with ixodid ticks, which can
transmit these microorganisms to humans and
animals via salivary secretions [1]. Several tick-
borne rickettsiae are causative agents of human
diseases characterized by various clinical features,
including headache, high fever, one or several
inoculation eschars (tache noire) at the bite site of
the tick and a rash [1].
In Italy, the incidence of tick-borne zoonoses has
increased over the last decade. From 1998 to 2002,
4604 clinical cases and 33 deaths were reported to
the Health Ministry [2]. The Italian regions with
elevated incidences of rickettsial diseases are Sicily,
Sardinia, Lazio and Calabria, whereas in other
areas, rickettsiosis is sporadic and related topatient
stay in an endemic zone. Almost all of the cases
reported in Italy are considered as cases of Med-
iterranean spotted fever (MSF). This disease is due
to Rickettsia conorii subsp. conorii and transmitted
by the bite of the brown dog tick, Rhipicephalus
sanguineus [1]. Until 2002, the only rickettsia iso-
lated from humans and ticks in Italy wasR. conorii.
However, in 2005 the ﬁrst case of R. massiliae was
retrospectively documented in a patient from
Sicily, Italy [3]. This is the only well-documented
case of a human infection with R. massiliae. Two
additional rickettsial pathogens have been
detected in ticks collected in Italy, i.e. R. aeschlima-
nnii and R. slovaca [4]. Moreover, in 2004, in
northern Italy, three cases of a mild form of
rickettsiosis were serologically established and
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attributed to R. helvetica [5]. The pathogenicity of
this rickettsia is still under discussion [1].
Sardinia is the second-largest island in the
Mediterranean Sea, with 1.6 million inhabitants,
and an area of 24 090 km2.Its temperate climate
(average annual temperature 15–30C) allows the
survival of many kinds of tick vectors. The most
common tick species on the island areRhipicephalus
spp., Haemaphysalis spp. and Dermacentor spp. [6].
In Sardinia, the number of notiﬁed clinical
cases of SFG rickettiosis, presumably MSF, has
been 11.9 for every 100 000 inhabitants, in con-
trast to the national average of 2.1 [7]. To our
knowledge, all the studies on rickettsiae con-
ducted in Sardinia have been based on clinical
and serological features only. There has been no
direct detection or isolation of rickettsiae from
ticks or humans in Sardinia. In the present study,
a PCR and a nucleotide sequence analysis of
ampliﬁed products was used to identify rickett-
siae in ticks from Sardinia.
MATERIALS AND METHODS
Tick collection
The study was performed in two areas in the north (Sassari)
and east (Ogliastra) of Sardinia; both of these regions are
characterized by a high prevalence of tick bite-related fever
in animal species and a high seroprevalence related to
rickettsioses in humans. From June to July 2007, 83 adult
ticks were collected from various animals (sheep, goats,
horses, cattle and dogs) and from vegetation. All ticks
removed from animals were engorged or partially engorged.
All ticks were brought to the laboratory of the Institute
Zooproﬁlattico, Sardinia (Sassari) and stored in vials con-
taining 70% ethanol at room temperature until DNA
extraction. Samples were thereafter delivered to Marseille,
France. The ticks were identiﬁed, to the species or genus
level, using taxonomic schemes [6].
DNA extraction
Ticks were immersed in distilled water for 10 min, dried on
sterile ﬁlter paper and crushed individually with a sterile
scalpel in Eppendorf tubes. Genomic DNA was extracted
using QIAgen columns (QIAamp tissue kit, Qiagen, Hilden,
Germany), according to the manufacturer’s instructions.
PCR ampliﬁcation and electrophoresis
PCR was performed using oligonucleotide primers Rp CS.
409p and Rp CS.1258n (Eurogentec, Seraing, Belgium), which
amplify a 750-bp fragment of the citrate synthase gene (gltA) of
Rickettsia, as previously reported [8]. The positivity of samples
was conﬁrmed by a second PCR using primers Rr 190.70, Rr
190.180 and Rr 190.701 for the ompA gene, which amplify a
629–632-bp fragment [9]. In addition, for the detected rickett-
siae with homology of <99.9% and 98.8% with the gltA and
ompA genes, respectively, of validated species, three more PCR
reactions were performed: (i) a PCR using a battery of primers
that amplify a 2400-bp fragment of the rickettsial ompB gene;
(ii) a PCR using a battery of primers that amplify a 3000-bp
fragment of the sca4 gene; and (iii) a PCR using a battery of
primers that amplify a 1500-bp rrs gene fragment as previously
recommended by the ESCMID Study Group for Coxiella,
Anaplasma, Rickettsia and Bartonella [10].
A negative control of DNA extracted from non-infected
laboratory ticks and a positive control of R. montanensis DNA
(one negative control for every 20 tested ticks in both cases)
were included in each test. Reactions were performed in
automated DNA thermal cyclers (GeneAmp PCR System 2400
and 9700; Applied Biosystems, Courtaboeuf, France). PCR
products were veriﬁed by electrophoresis in agarose (1%) gel
stained with ethidium bromide and examined under UV
transillumination. PCR products were puriﬁed using a
QIAquick Spin PCR puriﬁcation Kit (Qiagen) and sequenced
using a DNA sequencing kit (dRhodamine Terminator cycle
sequencing ready reaction; Applied Biosystems), according to
the manufacturer’s instructions. All sequences were assembled
and edited with Auto Assembler software (version 1.4; Perkin-
Elmer, Courtaboeuf, France) and compared with those of the
rickettsiae present in the GenBank database using the BLAST
search tool. Sequences obtained were aligned and analysed
using the ClustalW and Mega v.4 programs.
RESULTS
The ticks collected were identiﬁed as Rhipicephalus
bursa, Rhipicephalus turanicus, Hyalomma margina-
tum marginatum or Rhipicephalus sanguineus. One
damaged tick was identiﬁed to the genus level
only, as Rhipicephalus sp. (Table 1).
Rickettsial DNA was found in 15 (18%) of the
83 ticks examined using PCR with gltA-speciﬁc
and ompA-speciﬁc primers (Table 1). Seven of 11
H. marginatum marginatum ticks were found to be
positive for rickettsial DNA, using both PCR
reactions. For all samples, sequence analyses
showed 100% similarity with the 750-bp gltA
fragment and the 630-bp ompA fragment of
R. aeschlimannii. Two of 24 Rhipicephalus turanicus
ticks contained a rickettsia exhibiting a nucleotide
sequence of gltA with 99.6% (466 ⁄ 468 bp) simi-
larity to that of R. massiliae. The ompA sequence
showed 99.2% (494 ⁄ 498 bp) similarity to the
ompA sequence of R. massiliae. Both Rhipicephalus
sanguineus ticks tested positive by PCR. Sequence
analysis revealed 100% similarity to the corre-
sponding 750-bp fragment of gltA and the 630-bp
fragment of ompA of R. massiliae.
Four of 24 Rhipicephalus turanicus ticks were
PCR-positive for rickettsial DNA. The gltA and
ompA sequences from all validated species
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deposited in GenBank were found to be
different. They had 100% similarity to the
corresponding sequences of an incompletely
described rickettsia, temporarily named Rickettsia
PoTiRb169 (Table 1) [11]. When ompB sequences
were obtained from the same PCR-positive ticks,
they were shown to have 99.86% (774 ⁄ 775 bp)
similarity to the ompB sequence of Rickettsia
PoTiRb169. Sequences of the sca4 and rrs genes
were obtained and compared with those avail-
able in GenBank. Surprisingly, the sca4 sequence
had 98.92% similarity (2841 ⁄ 2872 bp) to that of
R. africae, whereas the rrs sequence had 99.45%
(1458 ⁄ 1466 bp) similarity to that of R. conorii. No
sequences of these two genes of Rickettsia
PoTiRb169 were available in GenBank. The
sequences of the ﬁve genes of this rickettsia
were obtained from the DNA extracted from the
four different Rhipicephalus turanicus ticks. The
respective sequences obtained from all four ticks
were identical.
None of the ticks belonging to the species
Rhipicephalus bursa were positive for rickettsiae.
All the Genbank accession numbers used to
compare the sequences obtained are presented
in Table 1. The phylogenetic relationships
between the rrs, ompB and sca4 genes among
the validated Rickettsia species and ‘Candidatus
Rickettsia barbariae’ are shown in Figure 1.
DISCUSSION
Our results document the ﬁrst detection in
Sardinian ticks of Rickettsia spp., including two
human pathogens, R. massiliae and R. aeschliman-
nii. R. massiliae is commonly found in Rhipiceph-
alus sanguineus and Rhipicephalus turanicus ticks.
Since its isolation and characterization in 1993
[12], R. massiliae has been found to infect ticks
in the European mainland, including France,
Greece, Spain [13], Portugal and Switzerland [1].
It has also been detected in engorged female
ticks of the Rhipicephalus sanguineus group col-
lected in Corsica, a French Mediterranean island
[14], as well as in Africa and recently the USA
[15]. Trans-stadial and transovarial transmission
of R. massiliae in Rhipicephalus sanguineus group
ticks has been reported [14]. Therefore, these
ticks can be considered as vectors but also as a
reservoir. Rhipicephalus sanguineus has become
the tick most widely distributed throughout the
climatic region of the Mediterranean area, where
it feeds on domestic dogs [6]. In the USA,
although R. conorii has never been described,
Rhipicephalus sanguineus has been implicated as a
vector of R. rickettsii, the agent of Rocky Moun-
tain spotted fever [15].
Rhipicephalus turanicus, on the other hand, is
distributed in southern Europe and northern
Table 1. Detection and identiﬁcation of spotted fever group rickettsiae from ticks, collected in Sardinia, by PCR and
sequencinga
Tick species
(number of tested
specimens) Host
Rickettsial gene
targeted ⁄number
of ticks positive
by PCR ⁄ total
examined
Animal
species
with positive
ticks
Identiﬁcation by
gene sequence
GenBank
accession
number
Hyalomma marginatum
marginatum (11)
Horses gltA 7 ⁄ 11 Horses Rickettsia aeschlimannii (100%) U59722.1
OmpA 7 ⁄ 11 R. aeschlimannii (100%) U43800.1
Rhipicephalus
sanguineus (2)
Dogs gltA 2 ⁄ 2 Dogs R. massiliae (100%) U59720.1
OmpA 2 ⁄ 2 R. massiliae (100%) U43792.1
Rh. bursa (45) Goats, cattle,
horses, sheep,
vegetation
gltA 0 ⁄ 45 – – –
OmpA 0 ⁄ 45 – –
Rh. turanicus (24) Sheep, cattle,
horses, goats
gltA 2 ⁄ 24 Cattle, goat R. massiliae (99.6%) U59719.1
OmpA 2 ⁄ 24 R. massiliae (99.2%) U43799.1
Rh. turanicus (24) Sheep, cattle,
horses, goats
gltA 4 ⁄ 24 Sheep ‘Candidatus Rickettsia barbariae’b EU272185
OmpA 4 ⁄ 24 ‘Candidatus Rickettsia barbariae’c EU272186
OmpB 4 ⁄ 24 ‘Candidatus Rickettsia barbariae’d EU272187
sca4 4 ⁄ 24 ‘Candidatus Rickettsia barbariae’e EU272188
rrs 4 ⁄ 24 ‘Candidatus Rickettsia barbariae’f EU272189
Rhipicephalus sp. (1) Dog gltA 0 ⁄ 1 – – –
OmpA 0 ⁄ 1 – –
aOnly ticks positive for gltA were tested for ompA.
b100% similar to the gltA sequence of Rickettsia PoTiRb169 (DQ423369.1).
c100% similar to the ompA sequence of Rickettsia PoTiRb169 (DQ423366.1).
d99.86% similar to the ompB sequence of Rickettsia PoTiRb169 (DQ423363.1).
e98.92% similar to the sca4 sequence of Rickettsia africae (AF151724.2).
f99.45% similar to the rrs sequences of Rickettsia conorii (AE008647.1).
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Africa [6]. For 12 years, R. massiliae has
been considered as a rickettsia of unknown
pathogenicity. However, in 2005, R. massiliae
was reported to be an emerging human
pathogen [3].
The second SFG pathogenic rickettsia found in
this study was R. aeschlimannii. This bacterium
has been found in H. marginatum marginatum
and H. marginatum ruﬁpes ticks collected in
southern Europe, including Corsica, an island
close to Sardinia [16], and Africa, and in
Rhipicephalus appendiculatus in South Africa [17].
H. marginatum marginatum is one of the most
important species in the Mediterranean region.
It is a vector but also a suspected reservoir of
R. aeschlimannii [6]. Only two cases of R. aeschli-
mannii infection have been described, including
one in a patient bitten in Morocco and one in
South Africa [1]. In the ﬁrst case, the patient
presented an inoculation eschar on his ankle,
fever, and a generalized maculopapular rash.
The second case was that of a patient returning
from a trip to South Africa. A Rhipicephalus
appendiculatus tick was attached to his thigh, and
an eschar around the attachment site was noted
[17].
We have also detected an incompletely de-
scribed rickettsia in Rhipicephalus turanicus ticks.
This rickettsia has recently been detected in
Portugal in a Rhipicephalus bursa tick, and has
provisionally been named PoTiRb169 [11]. The
analysis of gltA, ompA and ompB sequences
conﬁrmed the presence of this rickettsia in Sardi-
nia. As stated by de Sousa et al. [11], when they
reported the detection of this bacterium, other
gene sequences were required to establish its
identity correctly according to the genetic guide-
lines published by Fournier et al. [10,18]. That was
done in this study. The sequences of the rrs and
sca4 genes were determined and shown to be
different from those of all validated Rickettsia
species (Table 1). Considering these criteria, we
propose to give to this strain a Candidatus status
and name it ‘Candidatus Rickettsia barbariae’, with
reference to the name Barbaria given by Romans to
the Mountains of Sardinia.
The data of this study allowed the ﬁrst identi-
ﬁcation of rickettsiae in Sardinian ticks, and
provide the ﬁrst evidence of two human patho-
gens, R. massiliae and R. aeschlimannii, in this
region. The four ticks found to carry rickettsiae
had been collected in the same geographical area
(Ogliastra). However, DNA detection does not
imply transmission competence of the ticks con-
cerned, because they could have been removed
from bacteraemic animals. Therefore, further
investigations on the relationships between ticks
and this new rickettsia are needed.
The results presented here are of epidemio-
logical importance. Indeed, in Sardinia, only
R. conorii conorii, the agent of MSF, is considered
by the medical community, and all reported
cases are considered to be MSF. In this study,
R. conorii conorii was not detected. However,
two specimens only of its recognized vector,
Rhipicephalus sanguineus, have been tested. Fur-
thermore, the rate of infection of Rhipicephalus
sanguineus by R. conorii conorii in nature has
been found to be very low in every place where
it has been determined [1]. In Sardinia, the
incidence of SFG rickettsioses is very high in
comparison to that in other regions in Italy. The
present data raise the possibility that, in addi-
tion to MSF cases, a proportion of the cases
reported in Sardinia might be due to other
rickettsiae, including R. massiliae and R. aeschli-
mannii and also ‘Candidatus Rickettsia barbariae’.
The pathogenicity of this rickettsia is as yet
unknown. However, as shown recently with
other rickettsiae, it could emerge as a human
pathogen in the near future.
Clinicians in Sardinia should be informed that
several rickettsiae are prevalent on the
island. Further studies are needed to better
understand rickettsioses in Sardinia by
extending entomological surveys with an
increased number of tick species and tick
specimens. Furthermore, clinical investigations
using molecular or culture-based techniques are
expected to help identify rickettsiae in patients.
PCR and nucleotide sequencing are now used
as sensitive and rapid tools for the detection
and identiﬁcation of rickettsiae in blood, and
particularly in skin biopsies. Analysing skin
biopsies of inoculation eschars in patients
with spotted fever would be, together with
continuing entomological surveys, the best way
to increase our knowledge concerning tick-borne
rickettsioses in Sardinia and, more generally, in
the Mediterranean basin.
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